A detailed history of Corient Capital Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 15,947 shares of BSX stock, worth $1.44 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,947
Previous 15,947 -0.0%
Holding current value
$1.44 Million
Previous $594,000 -0.0%
% of portfolio
0.04%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $153,716 - $205,450
-4,362 Reduced 21.48%
15,947 $594,000
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $219,510 - $242,051
5,367 Added 35.92%
20,309 $899,000
Q4 2021

Feb 11, 2022

SELL
$38.07 - $44.87 $101,304 - $119,399
-2,661 Reduced 15.12%
14,942 $635,000
Q3 2021

Nov 16, 2021

BUY
$41.23 - $45.88 $76,399 - $85,015
1,853 Added 11.77%
17,603 $764,000
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $105,902 - $121,438
2,745 Added 21.11%
15,750 $673,000
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $72,303 - $81,323
2,050 Added 18.71%
13,005 $502,000
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $779,058 - $986,336
-23,501 Reduced 68.21%
10,955 $394,000
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $229,267 - $281,125
6,657 Added 23.95%
34,456 $1.32 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $528,294 - $684,385
17,499 Added 169.89%
27,799 $976,000
Q1 2020

May 06, 2020

SELL
$25.83 - $45.71 $267,805 - $473,921
-10,368 Reduced 50.16%
10,300 $336,000
Q4 2019

Feb 04, 2020

BUY
$37.87 - $45.37 $247,745 - $296,810
6,542 Added 46.31%
20,668 $935,000
Q3 2019

Nov 06, 2019

BUY
$40.31 - $43.45 $107,668 - $116,054
2,671 Added 23.32%
14,126 $575,000
Q2 2019

Aug 08, 2019

SELL
$34.91 - $42.98 $20,108 - $24,756
-576 Reduced 4.79%
11,455 $492,000
Q1 2019

May 10, 2019

BUY
$32.91 - $40.75 $142,730 - $176,732
4,337 Added 56.37%
12,031 $462,000
Q4 2018

Feb 07, 2019

BUY
$31.73 - $39.04 $244,130 - $300,373
7,694 New
7,694 $272,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.